Member Info for TotalWealth

Obsisian - it does your cause no good at all, by referring to some here as "BBM's" (bulletin board morons).

Please don't think you are superior or more learned in any way shape or form to us here - I usually find pseudo academics such as yourself usually make a horlocks of things in the long run - you've only got to look at the government's "advisors" to see that. Big words I'm afraid don't bamboozle me or 99% of the people here, so I for one will politely decline your "offer" of assistance where SVNS is concerned.

I wish you a good day.

MORAL OF THE STORY IS:-

If you are in a financial dilemma or your head is spinning DON'T go to a financial Psychologist!

Especially one called Obsisian !

Probably wants to buy in on the cheap in reality. To be fair, Elrico is very objective and fair at times, but I do think he's missed a lot of points on this one.

The 86% success rate and no mention of the Archer note are two glaring omissions for starters.

And going on about the £1m raise "not being anywhere near enough", really isn't cutting the mustard. Everyone knows what it's for, it was in the RNS - and as I said earlier, and most here think the same as it's already been hinted at by management, the odds on a partnership are high, and uniquely the NHS are involved in any case.

Overall it's not a good case that Elric puts and a shabby attempt at a deramp by Obsisian.

Thanks for the post Obsisian - but it's not telling anybody here something we don't already know.

It doesn't mention the current 86% success rate of the AUD drug under phase3 trials, a far better success rate than J&J can claim. Also we all are aware that there will be more funds needed to push SVN-001 through to a logical conclusion, but there is a strong feeling a partnership will be formed to take care of that - SVNS won't have to raise anywhere near the mooted £80m - that's a figure for the birds. I also notice the Charles Archer note which initially targets 1p isn't mentioned at all either in Lemming's piece.

Lemming Investor has always erred on the cautious side, but even with that steer he has to admit it's an "attractive speculative opportunity". I think we're all big enough here to recognise the risks and the due diligence.

Coming up!

The 0.3378's are buys, and the 0.332's are sales - so it's a nice balance trading day with the bias firmly to the upside.

Not often a small cap company raises a small amount like £1m and gets a reaction in it's share price as positive as this.

That's the Singer initial target price millie - that could happen anytime, more specifically if the phase3 trials are a success.

A superb post Nano - and you've wrapped up exactly what's going on here and the prevailing mood.

It's very rare for any pharma or therapeutical stocks to show so much interest with a potential to explode upwards due to varying factors - SVNS however are well ahead of the game on all fronts.

Spot on Bline - better not impart my true feelings here - I'd be banned for life!

Just to repeat what's already been said, and a strong pointer to future prospects, the funders who enabled at 0.13p would not have piled in again at 0.30p - a premium to the prevailing price - unless they had wind of very positive news to come. Nobody in that game throws good money after bad, so in my view there would have been some sort of hint put out.

Now people have had time to read the latest RNS I expect some serious buyers to come in from now.

Yes Bline. I was thinking of helping the hapless Reeves out of her "black hole", but thought better of it !

I haven't finished here by the way, would like to cement around 25m between us for the ride.

Wife and I holding just under 16.2m now in both SIPP's and ISA's.

Each to their own, of course, and nothing wrong with bagging a profit, but I must say selling after that announcement this morning doesn't look the right thing to do to me.

I wouldn't even consider a small top-slice until at least 1p and even then I'd be very reluctant given the two notes in the past few weeks. Remember, always the chance of the general press picking up on this company too with a Sunday BUY tip somewhere.

Holding very tight, long and strong.

Even though it's a relatively small amount, this news is far more important to me than it looks on the surface. A massive vote of confidence and it cements 0.30p now as a solid support base.

A partnership deal, phase 3 trial news or even the whiff of a bid (?) will send us flying. I think the speculation yesterday about the MM's possibly being a bit short of stock has come to pass.

Tricky - good morning. Your 500,000 bell late yesterday, albeit at a tad higher than you originally wanted, now looks very astute!

Very positive news indeed. A relatively small amount raised in relation to the current undervalued mcap, so not a big dilution, but also very important to note it was above the closing price yesterday, so a significant vote of confidence in things here by some decent contributors.

Also very positive in that it's all going to be used for the right things, and not as is usual with some smaller companies "working capital" (we know what that usually means, a few quid extra for the BOD and keep the lights on), the polar opposite here. Serious R&D plus the main clinical trial 3 drug almost knocking on the door.

Getting the buying boots on again.

0.2915 is not exactly gangbusters considering the amount, 10m, I'd have been happier to see that logged in at full ask, unless it's an order that's been worked through the day - there is some thought here, me included, that the MM's just may be a tad short of stock now the seller appears to have disappeared, so that price could be an average of a few tranches.

We'll see in the coming days how the sp reacts, especially to any news.

At least you got them Tricky - well done. I'm sure that little extra you paid won't go amiss in the long run.

Well, I'd be kicking ii into touch pronto.

Hardly a disaster - what's really the difference between 0.293 and 0.294?